News | Cardiac Diagnostics | August 24, 2016

Apollo Astronauts Experiencing Higher Rates of Cardiovascular-Related Deaths

Study suggests exposure to deep space radiation likely the cause

Apollo astronauts, cardiovascular death, FSU study, Florida State University, cosmic radiation

International Space Station image courtesy of NASA

August 24, 2016 — Members of the successful Apollo space program are experiencing higher rates of cardiovascular problems that are thought to be caused by their exposure to deep space radiation, according to a Florida State University researcher.

In a new paper in Scientific Reports, FSU Dean of the College of Human Sciences and Professor Michael Delp explains that the men who traveled into deep space as part of the lunar missions were exposed to levels of galactic cosmic radiation that have not been experienced by any other astronauts or cosmonauts. That exposure is now manifesting itself as cardiovascular problems.

“We know very little about the effects of deep space radiation on human health, particularly on the cardiovascular system,” Delp said. “This gives us the first glimpse into its adverse effects on humans.”

This is the first study looking at the mortality of Apollo astronauts. The Apollo program ran from 1961 to 1972, with 11 manned flights into space between 1968 and 1972. Nine of those flew beyond Earth’s orbit into deep space. The program is most notable for landing men on the moon as well as the failed mission of Apollo 13 that inspired the popular 1995 Ron Howard film.

Delp’s research is of special interest now as the United States and other nations, plus private organizations, make plans for deep space travel. NASA has unveiled plans for U.S. orbital missions around the moon from 2020 to 2030 in preparation for a manned flight to Mars. Russia, China and the European Space Agency are all looking at lunar missions. And SpaceX, owned by Elon Musk, has proposed landing humans on Mars by 2026.

As a group, astronauts are highly educated and have access to top medical care, meaning their healthcare outcomes are generally better than the general population. But the group of men in the Apollo program experienced different environmental conditions than anyone else in the world when they traveled into deep space.

Delp found that 43 percent of deceased Apollo astronauts died from a cardiovascular problem. That is four to five times higher than non-flight astronauts and astronauts who have traveled in low Earth orbit.

Of the 24 men who flew into deep space on the Apollo lunar missions, eight have died and seven were included in the study. The eighth — Edgar Mitchell — died after the data analysis had been completed.

Delp and his colleagues also exposed mice to the type of radiation that Apollo astronauts would have experienced. After six months — the equivalent of 20 human years — the mice demonstrated an impairment of arteries that is known to lead to the development of atherosclerotic cardiovascular disease in humans.

“What the mouse data show is that deep space radiation is harmful to vascular health,” Delp said.

Delp is working with NASA to conduct additional studies on the Apollo astronauts regarding their cardiovascular health.

 

Read the arrticle "The Heart of An Astronaut, Five Years After Space."
 

 

This research was funded by National Space and Biomedical Research Institute and the NASA Space Biology Program. Other authors on the paper include Jacqueline Charvat from Johnson Space Center, Charles Limoli from University of California Irvine, Ruth Globus from the NASA Ames Research Center and FSU postdoctoral researcher Payal Ghosh.

For more information: www.nature.com/srep

Related Content

AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG| August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies| August 04, 2017
In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of...
New Study Focuses on Protein Responsible For Increased Heart Disease Risk
News | Cardiac Diagnostics| August 03, 2017
August 3, 2017 — A study to reduce the strongest inherited...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Aug.
Philips released a new version of its iFR system that displays FFR readings as an overlay on live angiographic, angiogram images.

Philips released a new version of its iFR system that displays hemodynamic pressure drop points in an overlay on live angiographic images, matching up the iFR readings with corresponding lesions. The system is supposed to speed diagnostic decision making and help guide percutaneous revascularization procedures. 

Feature | FFR Catheters| July 31, 2017 | Dave Fornell
The gold standard for assessing the hemodynamic significance or coronary lesions to determine if they should be revas
Siemens Healthineers to Acquire Epocal from Alere
News | Point of Care Testing| July 26, 2017
Siemens Healthineers has entered into a definitive agreement to acquire Epocal Inc., a subsidiary of Alere Inc. Epocal...
New PET-CT Scan Improves Detection in Rare Cardiac Condition
News | PET-CT| July 25, 2017
Using a new imaging technique that can diagnose cardiac sarcoidosis much more accurately than traditional tests,...
3-D Vascular Ultrasound Quantifies Plaque Burden to Estimate Cardiovascular Risk
News | Cardiovascular Ultrasound| July 20, 2017
July 20, 2017 — In a large, first-of-its-kind population, researchers found an experimental technique known as...
More Than 20 Percent of Low-Risk Patients Receive Annual ECG
News | ECG| July 20, 2017
July 20, 2017 — More than one in five Ontario patients receive an ...
Alere point of care POC testing for INR
News | Point of Care Testing| July 17, 2017 | Dave Fornell
July 17, 2017 — Despite issues with point-of-care INR testing company Alere Inc., Abbott announced this week it is on
Overlay Init